Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsNASALStandard

VALTOCO

DIAZEPAM

Standard Dose
7.5MG/SPRAY
Max Dose
Refer to approved labeling
Primary Use
Review priority: N/A Marketing status: Prescription
Summary

Approval overview VALTOCO is listed in Drugs@FDA under application 211635 (NDA).

Review priority: N/A Marketing status: Prescription Active ingredient DIAZEPAM Form and strength SPRAY;NASAL - 7.5MG/SPRAY Sponsor NEURELIS INC Submission history Latest submission status date: 2025-06-14 00:00:00.

Structured Monograph

Clinical summary

Approval overview VALTOCO is listed in Drugs@FDA under application 211635 (NDA). Review priority: N/A Marketing status: Prescription Active ingredient DIAZEPAM Form and strength SPRAY;NASAL - 7.5MG/SPRAY Sponsor NEURELIS INC Submission history Latest submission status date: 2025-06-14 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: N/A

Interaction Notes

  • No interaction notes stored yet.
VALTOCO (DIAZEPAM) | Drug Monograph | MedicHelpline